Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address d ... evastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. read more